In trod uction
In a number of cells, including the pancreatic B-cell, cytoplasmic free Ca2+ ([Ca2+Ii) has a fundamental role in signal transduction. Over the years we have Abbreviations used: [Ca2+Ii, cytoplasmic free Ca2+ concentration; AC, adenylate cyclase; PLC, phospholipase C InsP,, inositol 1,4,5-trisphosphate; PKC, protein kinase C; OA, okadaic acid; ER, endoplasmic reticulum; CICR, CaZ + -induced CaZ + release. 'To whom correspondence should be addressed.
been able to demonstrate that [Ca2+Ii in the insulinsecreting B-cell is regulated by a sophisticated interplay between nutrients, hormones and neurotransmitters ( Figure 1 ). Glucose is readily taken u p by the B-cell and upon its metabolism ATP is formed. ATP will close specific ATP-regulated K+ channels and thereby trigger depolarization of the plasma membrane. This leads to opening of voltage-gated L-type Ca2+ channels, Ca2+ influx, increase in [Ca2+Ii and eventually insulin release [l] . This has led to the conclusion that there is
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Insulin Secretion and B-Cell Dysfunction These systems are also activated by various receptor agonists acting through G-proteins, resulting in the formation of cyclic AMP (CAMP), InsP, and DAG. DAG can also be formed directly from glucose metabolism through de novo synthesis. By activating protein kinase A (PKA), CAMP promotes phosphorylation of the voltage-gated L-type Ca2+ channel and thereby t o some extent increases Ca2+ influx. DAG activates PKC, an enzyme interacting with both the voltage-activated Ca2+ channels and the plasma membrane Ca2+ pump. PKC can also directly exert feedback inhibition of the PLC system (not discussed in the present paper). InsP, mobilizes intracellularly bound Ca*+, which in turn may promote CICR. Ca*+ originating from intracellular stores activates a low-conductance Ca*+-activated K+ channel (&a), resulting in repolarization of the plasma membrane and closure of the voltage-activated Ca2+ channels. Interestingly, the activity of the voltage-gated Ca2+ channels can also be modulated by calmodulin-dependent protein kinases (CAM) and serinekhreonine protein phosphatases (PPase). Note also that the proposed model requires that the B-cell is polarized, not only in terms of secretory granules (SG), but also voltage-gated Ca2+ channels, ER and &a. This means that Ca2+ influx through voltage-gated Ca2+ channels will take place in close contact with SG, thus initiating exocytosis. Ca2+ released from intracellular stores will preferentially activate &a, resulting in repolarization of the cell and thereby closure of the voltage-gated Ca2' channels. It is worth noting that the phosphorylation processes, induced by, for example, PKA. PKC and inhibition of PPases, may exert their main stimulatory effects on the B-cell stimulus-secretion coupling by direct interaction with the exocytotic machinery in a manner that is not directly correlated to changes in [Ca2+].
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generally a direct coupling between [Ca2+Ii and activity of the insulin secretory process. Hormones and neurotransmitters affect the B-cell through activation of receptors coupled to various effector systems. Examples of such receptor systems are adenylate cyclase (AC) and phospholipase C (PLC). When these systems are activated cyclic AMP is formed or phosphatidylinositol 4,s-bisphosphate is hydrolysed, the latter resulting in the formation of inositol 1,4,5-trisphosphate (InsPJ and diacylglycerol [l] . In addition to affecting the voltagegated L-type Ca2+ channels, cyclic AMP directly affects the exocytotic machinery; both effects are likely to be mediated by protein kinase A. InsP3 mobilizes intracellularly bound Ca2+, mainly from the endoplasmic reticulum (ER), and DAG activates protein kinase C (PKC). Although InsP, increases [Ca2+Ii, there is little effect on insulin release, suggesting that the trisphosphate has a role other than being primarily involved as a signal for exocytosis in the pancreatic B-cell. The physiological role of PKC is more clear. This enzyme is indeed involved as a modulator of multiple steps in the B-cell signaltransduction pathway. These steps involve the voltage-gated I,-type Ca2+ channel, the plasma membrane Ca2+ pump, the PLC system and the mechanism directly regulating exocytosis [2] .
It is well established that glucose stimulation of intact pancreatic islets promotes oscillations in 
Plasma membrane Ca2+ transport
The predominant Ca2+ current in the B-cell is carried by L-type Ca2+ channels (Figure 1 ). The activity of these channels is regulated by protein phosphorylation either directly, of the channel protein, or of associated regulatory proteins. Phosphorylating compounds, such as Mg-ATP, cyclic AMP and the catalytic subunit of protein kinase A, slow the time-dependent run-down of Ca2+ currents [8] . In the pancreatic B-cell, cyclic AMP does not seem to affect peak Ca2+ currents, but rather the rate of inactivation, thereby increasing the net influx of the ion [9, 101. It has been suggested that PKC has an inhibitory effect on the voltage-gated Ca2+ channel [ 113 and that stimulation of the enzyme leads to membrane depolarization and Ca2+ influx [ 121 in insulin-secreting cells. Whole-cell recordings have revealed a clear-cut increase in Ca2+ channel activity, subsequent to PKC activation [13] . In accordance with this, down-regulation of the enzyme results in a marked reduction of the voltage-dependent Ca2+ current, an effect that is associated with a delayed increase in [Ca2+Ii subsequent to glucose stimulation [14] . This implies that PKCinduced phosphorylation modulates the activity of voltage-gated L-type CaZ+ channels in the pancreatic B-cell ( Figure 1 ). Glucose may influence Ca2+ influx through voltage-dependent Ca2+ channels either by regulating membrane potential or by biochemically modulating the channel protein itself. The latter effect is likely to depend on DAG, formed upon glucose metabolism and then accounted for by PKC-induced phosphorylation [15] [16] [17] (Figure 1) .
A number of B-cell enzymes have been shown to be activated by Ca2+-calmodulin [18] [19] [20] . The calmodulin antagonist calmidazol inhibits influx of Ca2+ through voltage-gated I,-type Ca2 + channels in the B-cell [21] , suggesting that phosphorylation by calmodulin-dependent protein kinases is involved in the regulation of these channels ( Figure 1) .
With regard to possible effects of protein phosphatases on plasma membrane Ca2+ transport, our interest has recently been focused on the serinelthreonine protein phosphatases. Okadaic acid (OA) is a toxin that has been used extensively as a potent inhibitor of serine/threonine protein phosphatases type 1, type 2A and type 3 [22] . By using the whole-cell configuration of the patchclamp technique, we have shown an increase in the I,-type Ca2+ channel activity subsequent to acute application of OA to the pancreatic B-cell [23] . Moreover, our data suggest that this Ca2+ current is evoked at lower voltages in the presence of the phosphatase inhibitor. Therefore it seems that, in the pancreatic B-cell, serine/threonine protein phosphatases work in concert with various protein kinases in regulating the state of phosphorylation and thereby the threshold potential of the voltagegated L-type Ca2+ channels (Figure 1 ).
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IntraceIIuIar CaZ + transport
In mouse pancreatic B-cells, InsP3 releases about 30% of the Ca2+ sequestered into intracellular stores, most probably the ER [24] . This implies that the B-cell has both InsP,-sensitive, and InsP3-insensitive, non-mitochondria1 intracellular Ca2+ pools. While Ca2+ release by InsP3 is well established, a possible role for the trisphosphate in promoting Ca2+ sequestration by ER is not that clear. Interestingly, the ambient free Ca2+ concentration obtained in insulin-secreting RINmSF-cells, subsequent to InsP3-induced Ca2+ release, is lower than that before addition of the trisphosphate [25] . A similar effect was obtained in the presence of heparin, a blocker of Imp3-induced Ca2+ release [25] . Our data therefore suggest the presence of high-affinity InsPp-eceptors which operate continuously in the insulin-secreting cell. High concentrations of InsP3 will densensitize such receptors, while they are inhibited by heparin. Inositol 1,3,4,5-tetrakisphosphate did not promote Ca2+ sequestration in RINmSFcells.
Both thapsigargin and 2,5-di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ), two potent inhibitors of ER Ca2+-ATPase, dose-dependently mobilize Ca2+ from intracellular pools in electropermeabilized RINm5F-cells [26] . The magnitude of Ca2+ increase induced by either of the two inhibitors, is always smaller than that evoked by InsP3 and neither of them can empty the trisphosphatesensitive pool completely. Our data are in accordance with the existence of separate uptake and release compartments in the InsP3-sensitive pool in insulin-secreting cells. The two Ca2 + -ATPase inhibitors will then release Ca2+, predominantly from the uptake compartment, whereas Ca2+ located in the release compartment requires the presence of InsP3 for its release. Ca2 + -induced Ca2+ release (CICR) represents a phenomenon whereby an increase in [Ca2+Ii causes further release of Ca2+, by acting on specific receptor-operated channels located in the sarcoplasmic reticulum. The receptor for CICR is called the ryanodine receptor, because it specifically binds the plant alkaloid ryanodine [27] . Caffeine is another alkaloid which potentiates CICR [27] . Direct demonstration of CICR is difficult and therefore most studies have resorted to the use of ryanodine and caffeine to promote this process. CICR is not limited to the skeletal muscle, but rather a more general phenomenon documented in a number of different cell types 128-301. The sarcoplasmic reticulum ryanodine receptor contains sulphydryl groups, which upon oxidation change the conformation of the ryanodine receptor protein and thereby initiate the release of Ca2+ [31, 321. Thimerosal is a sulphydryl reagent that has been shown to sensitize CICR in non-muscle cells [33] . Interestingly, in electropermeabilized RINm5F-cells, thimerosal released Ca2+ from an InsP3-insensitive non-mitochondria1 intracellular Ca2 + pool in a dose-dependent matter [34] . Dithiothreitol, a reducing agent, reversed this release of Ca2+. Thimerosal-induced Ca2+ release was potentiated by caffeine, in keeping with an effect of the sulphydryl reagent on the CICR channel. Hence, our data suggest the existence of CICR in the pancreatic B-cell as well.
Cyclic ADP ribose is a newly discovered compound that is synthesized from NAD' by the ADP-ribosyl cyclases [ 3 5 ] . This enzyme is present in many mammalian and invertebrate tissues [36] and it has been suggested that cyclic ADP ribose may function as a general Ca2 + -mobilizing agent. In those cells where cyclic ADP ribose has a Ca2+-mobilizing activity, it is not clear whether the compound functions as a second messenger for an extracellular stimuli or mainly serves as a cofactor for CICR, by enhancing the sensitivity of the actual receptor to Ca2+. It has been suggested that glucose increases the levels of cyclic ADP ribose in the pancreatic B-cell, thereby serving as an important signal for intracellular Ca2 +-mobilization in this cell type [37] . This suggestion was based on weak experimental evidence, obtained from studies performed on microsomes prepared from pancreatic islets. The fact that the authors of that particular study were unable to show any stimulatory effect of InsP3, under the same experimental conditions where cyclic ADP ribose mobilized intracellular Ca2', sincerely questions the physiological relevance of this signalling pathway in the pancreatic B-cell. Moreover, in a recent study, taking a more physiological approach, we were unable to demonstrate any stimulatory effect of cyclic ADP ribose on Ca2+ mobilization in either normal pancreatic B-cells or clonal insulin-producing RINm5F-cells, under conditions where InsP3 always promoted Ca2+ release [38] . , will, in addition to various autocrine and neurocrine receptor agonists, promote the formation of InsP3, which together with CICR induces a localized release of intracellularly bound Ca2+. This results in the activation of a low-conductance CaZ + -activated K+ channel and, thereby, repolarization of the plasma membrane and closure of the voltage-gated L-type Ca2+ channels [39] . K+ currents of a similar type are evoked by hormones and neurotransmitters present in the B-cell micromilieu and also by intracellular application of compounds mobilizing Ca2+ from InsP3-sensitive Ca2+ stores. This suggests that the excitable pancreatic B-cell also exhibits InsP,-and Ca2 
Oscillations in [Ca2+],
Role of [Ca"], in exocytosis
For a long time it has been known that the exocytotic process of insulin in the B-cell can be modulated to a great extent, both positively and negatively, without any major concomitant changes in [Ca2+Ii. Examples of positive release signals are PKC and cyclic AMP, as convincingly demonstrated in both intact and permeabilized B-cells [40] . These signals probably evoke their effects by inducing phosphorylation of one or several sites that has a key function in regulating exocytosis. That cyclic AMP exerts most of its stimulatory effects on the B-cell stimulus-secretion coupling, by directly affecting the exocytotic machinery using protein kinase A-induced phosphorylation, was indeed confirmed in a recent study by Ammala et al. [41] . Moreover, a direct stimulatory role of phosphorylation was also evident from studies demonstrating that activation of PKC and inhibition of serine/threonine protein phosphatases promote exocytosis without any major effects on the B-cell handling of Ca2+ [23] (C. Ammala, I,. Eliasson, K.
Bokvist, P.-0. Berggren, R. E. Honkanen, A. Sjoholm and P. Rorsman, unpublished work). We have recently shown that the potent calmodulin antagonist calmidazol, although serving as an efficient blocker of Ca2+ influx through the voltage-gated L-type Ca2+ channels (see above), has a dramatic stimulatory effect on basal insulin release [21] . In this case, insulin release did not result from unspecific permeabilization of the B-cells and was not Looking at the regulation of exocytosis in more general terms, it is clear that there is no direct coupling between [Ca2+Ii and the final molecular mechanisms promoting the release process. This is not surprising in view of the very complex cellular mechanisms, including for example a number of socalled exocytotic proteins, that have been identified during recent years to be involved in regulating exocytosis in a number of various cell types.
Introduction
The insulin response to food ingestion is determined by the direct actions of glucose and certain amino acids on the pancreatic B-cell together with indirect actions generated through activation of both hormonal and neural arms of the enteroinsular axis [ 1-31. These signals are normally integrated at the level of the pancreatic B-cell such that insulin is secreted to appropriately regulate nutrient metabolism and glucose homeostasis. In non-insulindependent diabetes mellitus (NIDDM), defects in the mechanisms that regulate insulin secretion make a major contribution to the glucose intolerance and metabolic disarray associated with the disease [ 4-61. Possible molecular mechanisms underlying pancreatic B-cell dysfunction in NIDDM include site-specific defects in the stimulus-secretion coupling pathway and changes in B-cell function consequent to alterations in external influences on the B-cell. The participation and interaction of the various pathways to disturbances of insulin secretion in NIDDM are considered below in the framework of our present understanding of the regulation of B-cell function and stimulussecretion coupling.
Susceptible points in B-cell stimulussecretion coupling
Glucose insensitivity of the pancreatic B-cell lies at the heart of defective insulin secretion in NIDDM [4-61. Glucose is the principal regulator of B-cell function and also amplifies the insulinotropic actions of all other secretogogues, including enteroAbbreviations used: NIL)L)M, non-insulin-dependent diabetes mellitus; [CaL+] ,, cytoplasmic CaL+ concentration; K+-ATI', ATP-sensitive K + channel. 'To whom correspondence should be addressed. insular hormones and neurotransmitters [7] . It follows that each site in the series of steps linking B-cell glucose recognition to insulin discharge represents a potential influential lesion that might result in defective insulin secretion, characteristic of NIDDM. The normal secretory pathway induced by glucose starts with transport of the sugar into the B-cell by the GLUT2 glucose transporter (for comprehensive coverage of the pathway see [8-111). Phosphorylation of glucose, by glucokinase, and subsequent metabolism leads to the generation of ATP and increase of the ATPIADP ratio. This results in closure of ATP-sensitive K + channels (K+-ATP channels) in the B-cell membrane, depolarization, opening of voltage-dependent Ca2+ channels and CaZ+ influx. The resulting increase in cytoplasmic Ca2+ concentration ([Ca2+Ii) then triggers the secretory machinery, culminating in the discharge of insulin by exocytosis. Ca2+ also activates enzymes such as adenylate cyclase (with generation of cyclic AMP) and phospholipase C (with production of inositol 1,4,5-trisphosphate and diacylglycerol, which activates protein kinase C) that serve both to displace Ca2+ from intracellular stores and to sensitize the secretory machinery to [Ca2+Ii [ 101. Hormonal and neural elements of the enteroinsular axis potentiate the insulin secretory process through interactions with membrane receptors that are also linked to activation of adenylate cyclase or phospholipase C [7] .
Site-specific defects in 8-cell dysfunction
Site-specific defects in the pancreatic B-cell have been uncovered in studies evaluating mechanisms of defective insulin secretion using islets isolated from various animal models of NIDDM [6] . Less
